Your browser doesn't support javascript.
loading
Brain arteriolosclerosis.
Blevins, Brittney L; Vinters, Harry V; Love, Seth; Wilcock, Donna M; Grinberg, Lea T; Schneider, Julie A; Kalaria, Rajesh N; Katsumata, Yuriko; Gold, Brian T; Wang, Danny J J; Ma, Samantha J; Shade, Lincoln M P; Fardo, David W; Hartz, Anika M S; Jicha, Gregory A; Nelson, Karin B; Magaki, Shino D; Schmitt, Frederick A; Teylan, Merilee A; Ighodaro, Eseosa T; Phe, Panhavuth; Abner, Erin L; Cykowski, Matthew D; Van Eldik, Linda J; Nelson, Peter T.
Afiliação
  • Blevins BL; Department of Neuroscience, University Kentucky, Lexington, KY, 40536, USA.
  • Vinters HV; Department of Pathology and Laboratory Medicine, David Geffen SOM at UCLA and Ronald Reagan UCLA Medical Center, Los Angeles, CA, 90095-1732, USA.
  • Love S; University of Bristol and Southmead Hospital, Bristol, BS10 5NB, UK.
  • Wilcock DM; Sanders-Brown Center on Aging, Department of Neuroscience, University Kentucky, Lexington, KY, 40536, USA.
  • Grinberg LT; Department of Neurology and Pathology, UCSF, San Francisco, CA, USA.
  • Schneider JA; Global Brain Health Institute, UCSF, San Francisco, CA, USA.
  • Kalaria RN; LIM-22, Department of Pathology, University of Sao Paulo Medical School, São Paulo, Brazil.
  • Katsumata Y; Departments of Neurology and Pathology, Rush University Medical Center, Chicago, IL, 60612, USA.
  • Gold BT; Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK.
  • Wang DJJ; Sanders-Brown Center on Aging, Department of Biostatistics, University Kentucky, Lexington, KY, 40536, USA.
  • Ma SJ; Sanders-Brown Center on Aging, Department of Neuroscience, University Kentucky, Lexington, KY, 40536, USA.
  • Shade LMP; Laboratory of FMRI Technology (LOFT), USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Fardo DW; Laboratory of FMRI Technology (LOFT), USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Hartz AMS; Sanders-Brown Center on Aging, Department of Biostatistics, University Kentucky, Lexington, KY, 40536, USA.
  • Jicha GA; Sanders-Brown Center on Aging, Department of Biostatistics, University Kentucky, Lexington, KY, 40536, USA.
  • Nelson KB; Sanders-Brown Center on Aging, Department of Pharmacology and Nutritional Sciences, University Kentucky, Lexington, KY, 40536, USA.
  • Magaki SD; Sanders-Brown Center on Aging, Department of Neurology, University Kentucky, Lexington, KY, 40536, USA.
  • Schmitt FA; National Institutes of Health, Bethesda, MD, USA.
  • Teylan MA; Department of Pathology and Laboratory Medicine, David Geffen SOM at UCLA and Ronald Reagan UCLA Medical Center, Los Angeles, CA, 90095-1732, USA.
  • Ighodaro ET; Sanders-Brown Center on Aging, Department of Neurology, University Kentucky, Lexington, KY, 40536, USA.
  • Phe P; Department of Epidemiology, University Washington, Seattle, WA, 98105, USA.
  • Abner EL; Department of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Cykowski MD; Sanders-Brown Center on Aging, University Kentucky, Lexington, KY, 40536, USA.
  • Van Eldik LJ; Sanders-Brown Center on Aging, Department of Epidemiology, University Kentucky, Lexington, KY, 40536, USA.
  • Nelson PT; Departments of Pathology and Genomic Medicine and Neurology, Houston Methodist Hospital, Houston, TX, 77030, USA.
Acta Neuropathol ; 141(1): 1-24, 2021 01.
Article em En | MEDLINE | ID: mdl-33098484
ABSTRACT
Brain arteriolosclerosis (B-ASC), characterized by pathologic arteriolar wall thickening, is a common finding at autopsy in aged persons and is associated with cognitive impairment. Hypertension and diabetes are widely recognized as risk factors for B-ASC. Recent research indicates other and more complex risk factors and pathogenetic mechanisms. Here, we describe aspects of the unique architecture of brain arterioles, histomorphologic features of B-ASC, relevant neuroimaging findings, epidemiology and association with aging, established genetic risk factors, and the co-occurrence of B-ASC with other neuropathologic conditions such as Alzheimer's disease and limbic-predominant age-related TDP-43 encephalopathy (LATE). There may also be complex physiologic interactions between metabolic syndrome (e.g., hypertension and inflammation) and brain arteriolar pathology. Although there is no universally applied diagnostic methodology, several classification schemes and neuroimaging techniques are used to diagnose and categorize cerebral small vessel disease pathologies that include B-ASC, microinfarcts, microbleeds, lacunar infarcts, and cerebral amyloid angiopathy (CAA). In clinical-pathologic studies that factored in comorbid diseases, B-ASC was independently associated with impairments of global cognition, episodic memory, working memory, and perceptual speed, and has been linked to autonomic dysfunction and motor symptoms including parkinsonism. We conclude by discussing critical knowledge gaps related to B-ASC and suggest that there are probably subcategories of B-ASC that differ in pathogenesis. Observed in over 80% of autopsied individuals beyond 80 years of age, B-ASC is a complex and under-studied contributor to neurologic disability.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Arteriosclerose Intracraniana Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Animals / Humans Idioma: En Revista: Acta Neuropathol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Arteriosclerose Intracraniana Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Animals / Humans Idioma: En Revista: Acta Neuropathol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos